Corrigendum to: Clinical implication of an impaired fasting glucose and prehypertension related to new onset atrial fibrillation in a healthy Asian population without underlying disease: a nationwide cohort study in Korea

Corrigendum to: Clinical implication of an impaired fasting glucose and prehypertension related... Baseline data and contemporary management of adult patients with cardiomyopathies 1793 16. Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H, Camm AJ, . prevention in dilated cardiomyopathy post-DANISH: an updated meta-analysis and Ellinor PT, Gollob M, Hamilton R, Hershberger RE, Judge DP, Le Marec H, systematic review of randomized controlled trials. Clin Res Cardiol 2017;106:501–513. McKenna WJ, Schulze-Bahr E, Semsarian C, Towbin JA, Watkins H, Wilde A, 20. Masters J, Morton G, Anton I, Szymanski J, Greenwood E, Grogono J, Flett AS, Wolpert C, Zipes DP. HRS/EHRA expert consensus statement on the state of Cleland JG, Cowburn PJ. Specialist intervention is associated with improved genetic testing for the channelopathies and cardiomyopathies this document patient outcomes in patients with decompensated heart failure: evaluation of the was developed as a partnership between the Heart Rhythm Society (HRS) and the impact of a multidisciplinary inpatient heart failure team. Open Heart 2017; 4: European Heart Rhythm Association (EHRA). Heart Rhythm 2011;13: 1308–1339. e000547. 17. Walsh R, Thomson KL, Ware JS, Funke BH, Woodley J, McGuire KJ, Mazzarotto 21. Fumagalli S, Chen J, Dobreanu D, Madrid AH, Tilz R, Dagres N. The role of the F, Blair E, Seller A, Taylor JC, Minikel EV, Exome Aggregation Consortium, . Arrhythmia Team, an integrated, multidisciplinary approach to treatment of MacArthur DG, Farrall M, Cook SA, Watkins H. Reassessment of Mendelian patients with cardiac arrhythmias: results of the European Heart Rhythm gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference sam- Association survey. Europace 2016;18:623–627. ples. Genet Med 2017;19:192–203. 22. Priori SG, Blomstro ¨ m-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, 18. Orgeron GM, James CA, Te Riele A, Tichnell C, Murray B, Bhonsale A, Kamel IR, . Elliott PM, Fitzsimons D, Hatala R, Hindricks G, Kirchhof P, Kjeldsen K, Kuck KH, Zimmerman SL, Judge DP, Crosson J, Tandri H, Calkins H. Implantable Hernandez-Madrid A, Nikolaou N, Norekva ˚l TM, Spaulding C, Van Veldhuisen cardioverter-defibrillator therapy in arrhythmogenic right ventricular dysplasia/ DJ. 2015 ESC Guidelines for the management of patients with ventricular cardiomyopathy: predictors of appropriate therapy, outcomes, and complica- . arrhythmias and the prevention of sudden cardiac death: The Task Force for the tions. J Am Heart Assoc 2017;6:pii: e006242. doi:10.1161/JAHA.117.006242. Management of Patients with Ventricular Arrhythmias and the Prevention of 19. Wolff G, Lin Y, Karathanos A, Brockmeyer M, Wolters S, Nowak B, Fu ¨rnkranz A, Sudden Cardiac Death of the European Society of Cardiology (ESC). Eur Heart J Makimoto H, Kelm M, Schulze V. Implantable cardioverter/defibrillators for primary 2015;36:2793–2867. Corrigendum doi:10.1093/eurheartj/ehx635 Online publish-ahead-of-print 30 October 2017 .................................................................................................................................................... Corrigendum to: Clinical implication of an impaired fasting glucose and prehypertension related to new onset atrial fibrillation in a healthy Asian population without underlying disease: a nationwide cohort study in Korea [Eur Heart J (2017); 38 (34): 2599–2607]. The authors of the above article wish to inform readers that the following correction has been made post-publication: Figure 2 was cor- rected to replace 20< BMI 25 with 20 BMI< 25. Figure 2 The incidence of new onset AF, strokes, heart failure, and mortality according to the BMI (/100 000 person-years). (Left: BMI 2 2 2 2 <25 kg/m vs. BMI 25 kg/m ,right: BMI <20 kg/m vs. 20 BMI <25 kg/m ). (A) The incidence of AF according to the BMI (left, right), (B) The incidence of stroke according to the BMI (left, right), (C) The incidence of HF according to the BMI (left, right), (D) Mortality accord- ing to the BMI (left, right). AF, atrial fibrillation; HF, heart failure; HTN, hypertension; IFG, impaired fasting glucose; BMI, bodymass index. Published on behalf of the European Society of Cardiology. All rights reserved.V The Author 2017. For permissions, please email: journals.permissions@oup.com. Downloaded from https://academic.oup.com/eurheartj/article-abstract/39/20/1793/4582346 by Ed 'DeepDyve' Gillespie user on 21 June 2018 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Heart Journal Oxford University Press

Corrigendum to: Clinical implication of an impaired fasting glucose and prehypertension related to new onset atrial fibrillation in a healthy Asian population without underlying disease: a nationwide cohort study in Korea

European Heart Journal , Volume Advance Article (20) – Oct 30, 2017
Free
1 page

Loading next page...
1 Page
 
/lp/ou_press/corrigendum-to-clinical-implication-of-an-impaired-fasting-glucose-and-y6iMmGLbr5
Publisher
Oxford University Press
Copyright
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2017. For permissions, please email: journals.permissions@oup.com.
ISSN
0195-668X
eISSN
1522-9645
D.O.I.
10.1093/eurheartj/ehx635
Publisher site
See Article on Publisher Site

Abstract

Baseline data and contemporary management of adult patients with cardiomyopathies 1793 16. Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H, Camm AJ, . prevention in dilated cardiomyopathy post-DANISH: an updated meta-analysis and Ellinor PT, Gollob M, Hamilton R, Hershberger RE, Judge DP, Le Marec H, systematic review of randomized controlled trials. Clin Res Cardiol 2017;106:501–513. McKenna WJ, Schulze-Bahr E, Semsarian C, Towbin JA, Watkins H, Wilde A, 20. Masters J, Morton G, Anton I, Szymanski J, Greenwood E, Grogono J, Flett AS, Wolpert C, Zipes DP. HRS/EHRA expert consensus statement on the state of Cleland JG, Cowburn PJ. Specialist intervention is associated with improved genetic testing for the channelopathies and cardiomyopathies this document patient outcomes in patients with decompensated heart failure: evaluation of the was developed as a partnership between the Heart Rhythm Society (HRS) and the impact of a multidisciplinary inpatient heart failure team. Open Heart 2017; 4: European Heart Rhythm Association (EHRA). Heart Rhythm 2011;13: 1308–1339. e000547. 17. Walsh R, Thomson KL, Ware JS, Funke BH, Woodley J, McGuire KJ, Mazzarotto 21. Fumagalli S, Chen J, Dobreanu D, Madrid AH, Tilz R, Dagres N. The role of the F, Blair E, Seller A, Taylor JC, Minikel EV, Exome Aggregation Consortium, . Arrhythmia Team, an integrated, multidisciplinary approach to treatment of MacArthur DG, Farrall M, Cook SA, Watkins H. Reassessment of Mendelian patients with cardiac arrhythmias: results of the European Heart Rhythm gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference sam- Association survey. Europace 2016;18:623–627. ples. Genet Med 2017;19:192–203. 22. Priori SG, Blomstro ¨ m-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, 18. Orgeron GM, James CA, Te Riele A, Tichnell C, Murray B, Bhonsale A, Kamel IR, . Elliott PM, Fitzsimons D, Hatala R, Hindricks G, Kirchhof P, Kjeldsen K, Kuck KH, Zimmerman SL, Judge DP, Crosson J, Tandri H, Calkins H. Implantable Hernandez-Madrid A, Nikolaou N, Norekva ˚l TM, Spaulding C, Van Veldhuisen cardioverter-defibrillator therapy in arrhythmogenic right ventricular dysplasia/ DJ. 2015 ESC Guidelines for the management of patients with ventricular cardiomyopathy: predictors of appropriate therapy, outcomes, and complica- . arrhythmias and the prevention of sudden cardiac death: The Task Force for the tions. J Am Heart Assoc 2017;6:pii: e006242. doi:10.1161/JAHA.117.006242. Management of Patients with Ventricular Arrhythmias and the Prevention of 19. Wolff G, Lin Y, Karathanos A, Brockmeyer M, Wolters S, Nowak B, Fu ¨rnkranz A, Sudden Cardiac Death of the European Society of Cardiology (ESC). Eur Heart J Makimoto H, Kelm M, Schulze V. Implantable cardioverter/defibrillators for primary 2015;36:2793–2867. Corrigendum doi:10.1093/eurheartj/ehx635 Online publish-ahead-of-print 30 October 2017 .................................................................................................................................................... Corrigendum to: Clinical implication of an impaired fasting glucose and prehypertension related to new onset atrial fibrillation in a healthy Asian population without underlying disease: a nationwide cohort study in Korea [Eur Heart J (2017); 38 (34): 2599–2607]. The authors of the above article wish to inform readers that the following correction has been made post-publication: Figure 2 was cor- rected to replace 20< BMI 25 with 20 BMI< 25. Figure 2 The incidence of new onset AF, strokes, heart failure, and mortality according to the BMI (/100 000 person-years). (Left: BMI 2 2 2 2 <25 kg/m vs. BMI 25 kg/m ,right: BMI <20 kg/m vs. 20 BMI <25 kg/m ). (A) The incidence of AF according to the BMI (left, right), (B) The incidence of stroke according to the BMI (left, right), (C) The incidence of HF according to the BMI (left, right), (D) Mortality accord- ing to the BMI (left, right). AF, atrial fibrillation; HF, heart failure; HTN, hypertension; IFG, impaired fasting glucose; BMI, bodymass index. Published on behalf of the European Society of Cardiology. All rights reserved.V The Author 2017. For permissions, please email: journals.permissions@oup.com. Downloaded from https://academic.oup.com/eurheartj/article-abstract/39/20/1793/4582346 by Ed 'DeepDyve' Gillespie user on 21 June 2018

Journal

European Heart JournalOxford University Press

Published: Oct 30, 2017

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off